photo of coronavirus

The drug maker claims clinical trials of its new antiviral pill molnupiravir shows the drug halved the risk of hospitalization or death when given to high-risk people shortly after infection with COVID-19.

© 2005 - 2019 Ladocare. All rights reserved.

beautydailynews does not provide medical advice, diagnosis or treatment.

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending

Log in with your credentials

Forgot your details?